Gene Therapy AAV Vector Toxicities Get US FDA's Attention

Spotlight
US FDA is putting the spotlight on five types of toxicities with AAV gene therapy vectors. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Cell & Gene Therapies

More from Advanced Technologies